Medtech group Abbott has opened a new diabetes technology manufacturing plant in Kilkenny as part of a €440 million investment the company is making in two of its Irish facilities. More than 800 ...

More than 800 people will be employed at the plant, which will make more Libre sensors than any of the company’s other facilities. The company has invested in manufacturing capacity to increase supply ...

Abbott’s sensors lots that are considered for correction include T60001948, T60001966, and T60001969. Credit: Michael Vi / Shutterstock. Abbott has announced a voluntary medical device correction for ...

Abbott Laboratories has initiated a voluntary recall of a small number of FreeStyle Libre 3 sensors within three lots distributed throughout the US. Designed to be what the company says is the world’s ...

The US Food and Drug Administration (FDA) has cleared the Abbott Libre 2 and 3 continuous glucose monitoring (CGM) sensors for use during most imaging procedures, including MRI under certain ...

Tandem Diabetes Care's t:slim X2 Insulin Pump Automated Insulin Delivery System is now the first to incorporate the Abbott FreeStyle Libre 2 Plus Sensor for users in the United States. The FreeStyle ...

MISSISSAUGA, ON, July 8, 2025 /CNW/ -- Abbott (NYSE: ABT) today announced that its latest generation of sensor-based glucose monitoring technology, the FreeStyle Libre 3 Plus * sensor, is now ...

Abbott says the new Libre app provides a simplified view of data patterns, enabling Freestyle Libre CGM users to better understand the impact of food, activity, and insulin on glucose levels. [Image ...

MISSISSAUGA, ON, July 8, 2025 /CNW/ -- Abbott (NYSE: ABT) today announced that its latest generation of sensor-based glucose monitoring technology, the FreeStyle Libre 3 Plus * sensor, is now ...

CARLSBAD, Calif. — Advanced Diabetes Supply (ADS), a national distributor of diabetes devices under the ADS and US MED brands, is now carrying the new FreeStyle Libre 2 Plus sensor, the first DME ...